Mathew reported that a PCa patient undergoing radical prostatectomy and LH-RH therapy maintained castrated levels of serum testosterone level and undetectable serum PSA for 15 years before serum PSA level elevated. The gene discussed is GNRH1; the disease is posterior cortical atrophy.